Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210740 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
A Phase 2 study, sponsored by AmDerma.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT03210740 is a Phase 2 study that has completed, run by AmDerma. The registered enrollment target is 30 participants.
The verdict
NCT03210740, a Phase 2 study, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions
Interventions
- DRUG Vehicle Cream
- DRUG AM001 Cream, 7.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2018-04-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03210740
The ClinicalTrials.gov registry entry for NCT03210740 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AmDerma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Cream is the first listed.
NCT03210740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03210740 about?
NCT03210740 is a clinical study titled "Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis". To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions
What is the current status of trial NCT03210740?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2017-06-06. Estimated completion is 2018-04-24.
What interventions are being tested in trial NCT03210740?
The interventions under investigation include: Vehicle Cream (DRUG), AM001 Cream, 7.5% (DRUG).
Who is sponsoring clinical trial NCT03210740?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.